Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
International Journal of Immunogenetics
|
January 12, 2016
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight
M Garziera, E Catamo, S Crovella, et al.
Gut
|
January 1, 1995
DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease
F Bortoluzzi, M Valentini, C Cernigoi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 19, 2010
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
Valli De Re, R Cannizzaro, V Canzonieri, et al.
The Pharmacogenomics Journal
|
August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
E Cecchin, M D'Andrea, S Lonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients
G Toffoli, R Sorio, P Aita, et al.
Tissue Antigens
|
December 17, 2009
HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia
V De Re, L Caggiari, G Monti, et al.
Anti-Cancer Drugs
|
June 1, 1995
Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancer
M Gigante, R Sorio, A M Colussi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring
D Crivellari, D Lombardi, G Corona, et al.
Nanoscale
|
December 22, 2017
Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells
F Bertorelle, M Pinto, R Zappon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 5, 1998
Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis
G Franchin, E Minatel, C Gobitti, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
International Journal of Immunogenetics
|
January 12, 2016
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight
M Garziera, E Catamo, S Crovella, et al.
Gut
|
January 1, 1995
DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease
F Bortoluzzi, M Valentini, C Cernigoi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 19, 2010
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
Valli De Re, R Cannizzaro, V Canzonieri, et al.
The Pharmacogenomics Journal
|
August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
E Cecchin, M D'Andrea, S Lonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients
G Toffoli, R Sorio, P Aita, et al.
Tissue Antigens
|
December 17, 2009
HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia
V De Re, L Caggiari, G Monti, et al.
Anti-Cancer Drugs
|
June 1, 1995
Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancer
M Gigante, R Sorio, A M Colussi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2006
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring
D Crivellari, D Lombardi, G Corona, et al.
Nanoscale
|
December 22, 2017
Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells
F Bertorelle, M Pinto, R Zappon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 5, 1998
Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis
G Franchin, E Minatel, C Gobitti, et al.
Page
of 9